Deal Watch: Ionis Out-Licenses Pair Of Generation 2.5 Antisense Candidates

27 Nov 2017

• By Joseph Haas, Anju Ghangurde, and Jung Won Shin

Janssen and French biotech Dynacure take licenses to antisense candidates arising from Ionis’ Generation 2.5 technology. Merck and Cue sign autoimmune partnership, while Bayer and PeptiDream ink discovery pact.

Deal Watch: Ionis Out-Licenses Pair Of Generation 2.5 Antisense Candidates

More from Deals

More from Business